Virulence factors of Streptococcus agalactiae relating to neonatal sepsis

Wedeman M, Toluie A, Benton AH

Pdf Page Numbers :- 93-97

Melissa Wedeman¹, Ava Toluie¹, and Angela H. Benton^1,*

¹Lake Erie College of Osteopathic Medicine, 5000 Lakewood Ranch Blvd, Bradenton, FL 34211, USA

*Corresponding author: Angela Benton, Lake Erie College of Osteopathic Medicine, 5000 Lakewood Ranch Blvd, Bradenton, FL 34211, USA. Tel.: 1(941)-782-5910; Email: abenton@lecom.edu

Received 5 October 2023; Revised 28 November 2023; Accepted 8 December 2023; Published 12 December 2023

Citation: Wedeman M, Toluie A, Benton AH. Virulence factors of Streptococcus agalactiae relating to neonatal sepsis. J Med Sci Res. 2024; 12(1):93-97. DOI: http://dx.doi.org/10.17727/JMSR.2024/12-17

Copyright: © 2024 Wedeman M et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PDF

Abstract

Streptococcus agalactiae (Group B Streptococcus, GBS) infection is the leading cause of disease in neonates. Infection in the neonate can occur via vertical transmission or ascension through the vaginal tract. After ascension, infection of the amniotic fluid occurs via several virulence factors which allow for invasion of the placental membrane and chorioamniotic membranes. Neonatal infection is categorized into either early-onset sepsis or late-onset sepsis, with both being able to result in severe illness or even death. Prevention of GBS infection in the mother and neonate to this point includes neonatal screening at 35-37 weeks and treatment in GBS positive patients with IV penicillin. In those with allergies, cefazolin or clindamycin may be substituted. Documented increases in antibiotic resistance have led to the need for further research surrounding virulence factors. This outline summarizes several virulence factors including the hemolytic pigment, hyaluronidase, pili, adhesins, and the sialic rich capsular polysaccharide, that have been identified as key to colonization and infection of the neonate. Understanding of the virulence factors and incorporating prior deletion studies allows for advancements in treatment and prevention to be made. Novel theories will open the door for further research towards implementation of a vaccine as a means for preventing colonization.

Keywords: Streptococcus; agalactiae; neonates; vaginal tract